International
- What We Do
- Where We Work
- Who We Are
- Leaders
- Experts
- Our Studies
- Policy Research
- Social Science Research
- Social Science Research
- An exploratory study of fishing communities in Uganda to determine suitability as candidate populations for HIV-prevention trials
- Ensuring quality of services in HIV-prevention research settings: findings from a multi-center quality improvement pilot in East Africa
- New vaccine introduction in Tamil Nadu: a case study of the HPV vaccine
- Barriers and opportunities for involving MSM and transgender (TG) communities in HIV-prevention research in four cities in India
- AIDS vaccine research participation in Kenya: understanding gender-related barriers and social impact
- Social Science Research
- Observational Epidemiology
- Clinical Trials
- Clinical Trials
- IAVI R001
- IDEA EV06
- N004 (HIVCORE 004)
- X001
- PAVE 100
- IAVI V002
- IAVI 006
- IAVI B004
- IAVI B002
- IAVI B003
- IAVI C001
- IAVI 009
- IAVI 008
- IAVI 005
- IAVI 004
- IAVI 003
- IAVI 016
- IAVI P001
- IAVI B001
- IAVI V001
- IAVI D001
- IAVI C004/DHO-614
- IAVI C003
- IAVI C002
- IAVI A002
- IAVI A001
- IAVI 011
- IAVI 010
- IAVI 002
- IAVI P002
- IAVI 001
- IAVI N004/ HIV-CORE 004
- IAVI A003
- IAVI S001
- Clinical Trials
- Our Studies
- Partner
- Leaders
- Compensation Philosophy
- Seth Berkley, Founder
- Our History
- Advisory Committees
- Board of Directors
- Governance
- Rajat Goyal
- Bonnie Bender
- Lisa Meadowcroft
- Anthony Musyoka
- Labeeb Abboud
- Louis Schwartz
- Wayne Koff
- Margaret McGlynn
- IAVI Strategic Plan 2011-2015
- Benefits
- Careers that make a difference
- About Us
- Leaders
- Experts
- Social Science Research
- An exploratory study of fishing communities in Uganda to determine suitability as candidate populations for HIV-prevention trials
- Ensuring quality of services in HIV-prevention research settings: findings from a multi-center quality improvement pilot in East Africa
- New vaccine introduction in Tamil Nadu: a case study of the HPV vaccine
- Barriers and opportunities for involving MSM and transgender (TG) communities in HIV-prevention research in four cities in India
- AIDS vaccine research participation in Kenya: understanding gender-related barriers and social impact
- Observational Epidemiology
- Clinical Trials
- IAVI R001
- IDEA EV06
- N004 (HIVCORE 004)
- X001
- PAVE 100
- IAVI V002
- IAVI 006
- IAVI B004
- IAVI B002
- IAVI B003
- IAVI C001
- IAVI 009
- IAVI 008
- IAVI 005
- IAVI 004
- IAVI 003
- IAVI 016
- IAVI P001
- IAVI B001
- IAVI V001
- IAVI D001
- IAVI C004/DHO-614
- IAVI C003
- IAVI C002
- IAVI A002
- IAVI A001
- IAVI 011
- IAVI 010
- IAVI 002
- IAVI P002
- IAVI 001
- IAVI N004/ HIV-CORE 004
- IAVI A003
- IAVI S001
- Observational Epidemiology
- MONITORING TRENDS IN HIV PREVENTION RESEARCH FUNDING
- ESTIMATING THE POTENTIAL IMPACT OF AN AIDS VACCINE IN DEVELOPING COUNTRIES
- Rick King
- Pat Fast
- Fran Priddy
- Labeeb Abboud
- Wayne Koff
- Margaret McGlynn
- Our Spokespeople
- Clinical Trials
- Social Science Research
- Policy Research
- Our Studies
- Experts
- Social Science Research
- Partners
- How To Help
- Donate
- Learn
- Engage
- Volunteer
- Social Media
- Events
- HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P)
- AIDS2014: The 20th International AIDS Conference
- 2015 and Beyond: The Role of Innovation for Health in a New Development Framework
- The International Conference on AIDS and STDs in Africa
- First Biennial Scientific Conference on Medicines Regulation in Africa
- UN General Assembly Week 2013
- South African National AIDS Council Biennial Women's HIV Prevention Summit
- AIDS Vaccine 2013
- IAVI and Partners at SA AIDS
- The New York Academy of Sciences - Three Zeros of Eliminating HIV / AIDS: Global Science and Policy
- IAVI CEO Margie McGlynn Testifies Before U.S. House Appropriations Subcommittee on State, Foreign Operations on Funding for AIDS Vaccine R&D
- IAVI in the News
- Partner News
- Press Releases
- Publications
- Subscribe
- Information Center
- Donate Now
- Publications
- Press Releases
- 2015
- IAVI WELCOMES PROMISING STUDY
- FAST-REPLICATING HIV STRAINS DRIVE INFLAMMATION AND DISEASE PROGRESSION
- IAVI RECEIVES GSK FUNDING FOR THE HUMAN VACCINES PROJECT TO ACCELERATE DEVELOPMENT OF VACCINES FOR INFECTIOUS DISEASES AND CANCER
- CREATING AN AFRICAN HIV CLINICAL RESEARCH AND PREVENTION TRIALS NETWORK
- GSK GLOBAL VACCINES CHAIRMAN MONCEF SLAOUI JOINS IAVI BOARD OF DIRECTORS
- 2014
- IAVI Welcomes New Vice President of External Relations, Lisa Meadowcroft
- IAVI Welcomes Korean Women against AIDS to India
- IAVI Commemorates Partners Lost on Flight MH17
- IAVI Pays Tribute to Victims of the Malaysia Airlines Tragedy
- Declining Investment Could Slow Research and Rollout of New HIV Prevention Options
- Toward a Human Vaccines Project
- Aids: Don't Die of Prejudice: Compelling Picture of Today's HIV/AIDS Epidemic
- IAVI Commemorates the Life of Dr. Ciro de Quadros, Former Board Member and Public Health Expert
- Together, We Can Achieve a World Without AIDS
- It’s Time For AIDS, TB and Malaria to Go the Way of Smallpox and Polio
- Scientists Find New Point of Attack on HIV for Vaccine Development
- IAVI CEO Margie McGlynn Submits Testimony to U.S. House Appropriations Subcommittee on State, Foreign Operations and Related Programs on Funding for AIDS Vaccine R&D
- IAVI Congratulates New U.S. Global AIDS Coordinator, Deborah Birx
- IAVI Applauds Landmark Study Mapping Evolution of bNAb Against HIV
- IAVI and Partners Initiate Early Clinical Study of New Strategy to Help Prevent HIV
- Achieving a Sustainable End to AIDS Will Require HIV Vaccine, Says Anthony S. Fauci of NIAID
- IAVI Applauds News of Promising New Approach to Vaccine Design
- IAVI Mourns Passing of Dr. Reinhard Kurth, Former Scientific Advisory Committee Chair
- IAVI Congratulates Deborah Birx, MD, on Her Nomination as the Next U.S. Global AIDS Coordinator
- 2013
- IAVI Receives RWJF Grant to Catalyze a Human Vaccines Project
- Alex Coutinho Becomes Chair, Eric Goosby and Lord Fowler Join IAVI Board
- In Memoriam: Nelson Mandela (1918 - 2013)
- World AIDS Day - December 1, 2013: Honoring Their Memories. Finding a Vaccine.
- IAVI Excited About Progress That Detailed Picture of HIV Envelope Protein Can Bring to Fight Against AIDS
- IAVI Shares Recent NIAID Comments in Three Major Publications
- Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV May Be Feasible, Study Finds
- IAVI AND PARTNERS INITIATE PHASE I TRIAL OF A NOVEL AIDS VACCINE REGIMEN
- U.K. Government Pledges Renewed Funding to Support IAVI
- Saluting Nelson Mandela, a Champion of AIDS Awareness
- HIV Research Pioneer Dr. Robin Weiss Appointed Chair of IAVI’s Scientific Advisory Committee
- PrEP Used by Intravenous Drug Users Cuts HIV Infection Risk – IAVI Statement
- Leading Scientists Call for a Human Vaccines Project in Science
- World AIDS Vaccine Day 2013 – IAVI Statement
- NIH Announces It Has Discontinued Immunizations in AIDS Vaccine Clinical Trial HVTN 505
- Product Development Partnerships Applaud Japan’s First Public-Private Partnership to Spearhead Innovation in Global Health
- Researchers Develop a Promising New Technology to Aid HIV Vaccine Design
- IAVI CONGRATULATES MARIJKE WIJNROKS ON APPOINTMENT AT GLOBAL FUND
- IAVI Congratulates Dr. Alex Coutinho and Dr. Peter Piot, Winners of Japan’s Prestigious Africa Health Prize
- IAVI Celebrates International Women’s Day
- New Senior Level Appointments in IAVI’s Medical Affairs Department
- 2012
- World AIDS Day Statement 2012
- IAVI Headquarters temporarily relocated due to Hurricane Sandy
- PATH Malaria Vaccine Initiative Creates New Central Reference Lab
- International Symposium On Accelerating India’s Response to Research for a Preventive HIV Vaccine
- IAVI Welcomes New Members to Board of Directors
- A decade of progress and sustained funding for HIV prevention research provides a pathway for ending AIDS
- Aeras and the International AIDS Vaccine Initiative Partner to Advance Vaccine Research
- IAVI Commends U.S. FDA on Landmark Decision
- IAVI Extends Congratulations to Leading AIDS Vaccine Researchers
- IAVI Welcomes Louis Schwartz as Chief Financial Officer
- Study Reports Data on the Use of Intermittent ARV-Based Pre-Exposure Prophylaxis for HIV Prevention
- IAVI Commemorates World AIDS Vaccine Day
- IAVI, GlycoMimetics, and Glycosensors and Diagnostics Collaborate to Develop Novel AIDS Vaccine Candidate
- AIDS Vaccine Development Leader Esparza Awarded Congressional Medal of Merit
- Leading Global Health Expert Dr. Adel A.F. Mahmoud Joins IAVI Board of Directors
- IAVI Partners With Belgium-Based Biotech
- IAVI, NineSigma Collaborate to Identify New AIDS Vaccines Development Approaches
- 2011
- IAVI and Partners Initiate AIDS Vaccine Trial
- IAVI Applauds Clinton's Support for LGBT Rights
- Getting to Zero calls for Sustained Commitment
- Mary Tydings Joins IAVI Board
- IAVI Congratulates RTS,S on Positive Results
- AIDS Researchers Isoloate New Potent and Broadly Effective Antibodies Against HIV
- Report on HIV Prevention Research Funding Says New Investment Critical to Capitalize on HIV Prevention Research Breakthroughs
- IAVI Applauds Results of Studies Evaluating the Use of Antiretrovirals to Prevent HIV
- IAVI Appoints Margaret McGlynn President & Chief Executive Officer
- International AIDS Vaccine Initiative Awarded 10th Consecutive 4-Star Rating by Charity Navigator
- IAVI Marks the Third Decade of the AIDS Pandemic
- IAVI Statement for World AIDS Vaccine Day
- IAVI Congratulates HPTN 052 Collaborators on Positive Trial Results
- IAVI Announces Launch of Fellowship Program in AIDS Vaccine Research and Development
- IAVI Responds to the News of Planned FEM-PrEP Trial Closure
- 40 Organizations Call for Delegates at UN High-Level Meeting to Intensify R&D Investments for New HIV-Prevention Methods
- IAVI Congratulates Its CEO on New Appointment
- THSTI & IAVI Announce New HIV Vaccine Design Program in India
- IAVI and Partners Initiate AIDS Vaccine Trial in Africa
- IAVI Statement on Murder of Ugandan Activist David Kato
- 2010
- Progress in Prevention on World AIDS Day
- Jane Waterman to Join IAVI
- IAVI Commends iPrEX Collaborators on Positive Test Results
- NineSigma and IAVI partner to seek innovative solutions to AIDS vaccine challenges
- Phase I AIDS Vaccine Trial Starts, Testing a Prime-Boost Combinatio
- IAVI-led Team Wins Major Grant to Study HIV-neutralizing Antibodies
- Senior Merck Executive to Head IAVI’s AIDS Vaccine Design and Development Laboratory
- Advances on HIV Prevention Tools Heralded At Conference
- Report Warns Flat Global Funding for HIV Prevention Research May Limit Ability of Researchers to Move Promising Approaches Forward
- IAVI Congratulates CAPRISA on Positive Microbicide Trial Results
- International AIDS Vaccine Initiative Awarded 9th Consecutive 4-Star Rating by Charity Navigator
- Margaret McGlynn, Former President of Global Vaccines at Merck, Joins IAVI Board
- Japan Contributes $10 Million for AIDS Vaccine Development
- IAVI Statement for World AIDS Vaccine Day
- IAVI and Lentigen to Collaborate on Design of Novel AIDS Vaccine Candidate
- David N. Cook joins IAVI as Chief Operating Officer
- 2009
- IAVI Statement in Response to MDP 301 Phase III Trial of a Vaginal Microbicide
- OPEC Fund for International Development Becomes IAVI's Newest Partner
- IAVI 2009 World AIDS Day Statement
- World AIDS Day Community Statement
- Phase I Study of Preventive HIV Vaccine Shows Improved Immune Responses
- Case Studies Offer Inside Look at Effective Ways to Address Global Health Challenges
- IAVI Applauds End of U.S. Travel Ban on HIV-Infected Visitors
- Momentum Seen in AIDS Vaccine Research and Development
- Two Leading Research Institutions Partner to Accelerate the Development of an AIDS Vaccine Candidate
- IAVI Statement on Results of Phase III ALVAC-AIDSVAX Trial in Thailand
- The Scripps Research Institute and IAVI Launch Research Center
- Two New Antibodies Found to Cripple HIV
- Dianne Stewart Joins IAVI
- IAVI Receives 4-Star Charity Navigator Rating for Eighth Year in a Row
- New report finds first decline in HIV vaccine R&D investment in a decade
- IAVI and Theraclone Expand HIV Antibody Discovery Collaboration
- New Advances on the Long Road to the Development of an AIDS Vaccin
- Leading Vaccine Discovery Expert Joins IAVI
- TIME Names Dr. Seth Berkley One of 100 Most Influential People in the World
- 2008
- IAVI Posts $150,000 Challenge on InnoCentive
- IAVI Launches Video Commitments Project
- Phase I Clinical Trial to Test Combination of Two HIV Vaccine Candidates Starts in London
- Call for Volunteers for New AIDS Vaccine Trial
- IAVI Responds to Lancet Article on Intensive Testing and Treatment
- Honorees Herald Opening of New Design Lab
- Congresswoman Supports IAVI Lab Opening
- IAVI Commends UK Government’s Commitment to Ending AIDS
- IAVI Receives 4-Star Charity Navigator Rating
- Elevation Biotech and IAVI Partner To Develop HIV Vaccines
- Scripps and IAVI Launch Neutralizing Antibody Center
- IAVI and Indian Government Announce Results of Phase I AIDS Vaccine Trial
- Inovio Biomedical Expands In Vivo Electroporation License with IAVI
- Mexico City AIDS 2008
- IAVI Launches 2008 AIDS Vaccine Blueprint in Mexico City
- Investment in AIDS Vaccine and Microbicide RandD in 2007
- New UNAIDS Report Reveals Global AIDS Epidemic Slowing
- Global Health Technologies Coalition Statement
- IAVI Responds to NIAID Decision on PAVE 100 Trial
- Leading Vaccine Expert Joins IAVI
- IAVI Awards Latest Innovation Fund Grants
- World AIDS Vaccine Day 2008
- New Markets Tax Credit Helps Finance Lab Construction
- IAVI and CHAVI Team Up on AIDS Vaccine Development
- Latest AIDS Prevention News
- IAVI and VaxDesign Partner to Develop an AIDS Vaccine Clinical Trial in a Test Tube
- Carraguard Microbicide Safe but Not Effective
- IAVI Statement in Response to UK Media Coverage of Baltimore’s Remarks at AAAS
- Further Analysis of STEP AIDS Vaccine Trial Reaffirms Earlier Trend
- 2007
- IAVI teams up with Yahoo! to raise US$100K
- BD Renews Commitment to AIDS Vaccine Research
- IAVI Observes World AIDS Day 2007
- Henry Schein Joins IAVI Corporate Philanthropy Program
- UNAIDS and WHO Revise Stats on Global AIDS Epidemic
- Phambili HIV Vaccine Trial Stopped
- Finance Ministers Support Expanded Funding for AIDS Vaccine R&D
- IAVI Responds to the Announcement that Merck's AIDS Vaccine Candidate Trial Demonstrated a Lack of Efficacy
- University of Tokyo Researcher and IAVI Enter Collaboration
- New Data Redefining Laboratory Reference Ranges in Africa
- Japan's DNAVEC and IAVI Partner on Novel AIDS Vaccine Strategy
- IAVI States Facts Relating to Dismissal of South African Deputy Health Minister
- IAVI Signs Lease To Become First Tenant in New Bioscience Center in Brooklyn
- IAVI and Joaquim Chissano Foundation Sign MOU for Advocacy in Southern Africa
- Spanish Government Contributes One Million Euro for AIDS Vaccine Development
- G8 Leaders Highlight Importance of Effectively Combating Infectious Diseases
- World AIDS Vaccine Day 2007
- India's Department of Biotechnology and IAVI Forge Partnership
- The International AIDS Vaccine Initiative Receives 4-Star Charity Navigator Rating for Sixth Year in a Row
- IAVI Mourns Loss of Ugandan AIDS Vaccine Researcher
- IAVI Welcomes New Canadian Collaborative Initiative
- Vaccines for the Future Act of 2007
- IAVI Encourages Nations Worldwide To Support Advance Market Commitments
- IAVI Mourns the Death of Kenya AIDS Vaccine Initiative Director Job Bwayo
- AIDS Vaccine Clinical Trials in 24 Countries
- 2006
- IAVI Statement on Male Circumcision As Prevention Option
- European Governments Invest in AIDS Vaccine Development
- Canada Renews Support for AIDS Vaccine Research
- IAVI Supports World AIDS DAY
- IAVI Launches Southern African Programme
- IAVI Applauds India-Brazil-South Africa Trilateral Cooperation on AIDS Vaccine Development
- IAVI Calls For New Measures To Accelerate The Search For An AIDS Vaccine
- G8 Leaders Highlight the Importance of Effectively Combating Infectious Diseases
- UNGASS + 5 Support of AIDS Vaccines
- IAVI’s Neutralizing Antibody Consortium Accelerates AIDS Vaccine Research Efforts
- IAVI Calls for Continued Global Leadership: UNGASS
- IAVI Marks World AIDS Vaccine Day
- Leading Senior Pharmaceutical Company Executives Join IAVI
- Zambia Begins First Preventive HIV Vaccine Trial
- IAVI – NIH Sign Collaborative Agreement For Neutralizing Antibody Consortium
- The Kenya Medical Research Institute (KEMRI) and IAVI Inaugurate New HIV Prevention Research Facilities in Kilifi, Kenya
- IAVI Grants Harvard Researchers License To Use AIDS Vaccine Production Technology
- IAVI Joins Women’s Organizations Worldwide in Support of a Compact to End HIV/AIDS
- The Uganda Virus Research Institute (UVRI), in collaboration with IAVI and Targeted Genetics Launches AIDS Vaccine Trial in Uganda
- India Council of Medical Research National AIDS Control Organization and IAVI launch India’s Second AIDS Vaccine Trial
- Kenya AIDS Vaccine Initiative, IAVI and NIH Launch Trial of AIDS Vaccine
- Archives
- Project San Francisco IAVI and NIH Launch Rwanda’s First AIDS Vaccine Trial
- South Africa Begins First Phase II HIV Vaccine Trial
- Public-Private Partnerships Play a Critical Role in Creating Solutions for Neglected Diseases
- G8 Leaders Highlight the Importance of a Comprehensive Approach to HIV/AIDS for Africa’s Future
- IAVI President and CEO Testifies on AIDS Vaccines Before U.S. Senate Committee on Foreign Relations
- GSK Biologicals and IAVI Partner to Develop AIDS Vaccine
- Country Director of India Anjali Nayyar appointed Vice President of Country Regional Programmes
- Call for World Leaders to Redouble Efforts to Develop Vaccines and Microbicides to Prevent HIV
- On World AIDS Vaccine Day, progress and challenges
- March 23, 2005 Pleasanton, CA - March 23, 2005. Juvaris BioTherapeutics Inc., a private biotechnology company, today announced a research collaboration with the International AIDS Vaccine Initiative (IAVI) to use Juvaris' immunostimulant technology in t
- Juvaris BioTherapeutics Announces Collaboration IAVI
- India begins its first preventive AIDS vaccine trial
- Healthy Volunteers Sought for Trial of New Investigational AIDS Vaccine in New York City
- IAVI statement on 2004 HIV/AIDS statistics
- September 14, 2004 Leiden, The Netherlands, September 14, 2004 – Dutch biotechnology company Crucell and the International AIDS Vaccine Initiative (IAVI) have signed an exclusive license agreement to develop an AIDS vaccine based on Crucell’s AdVac® tec
- September 09, 2004 NEW YORK, September 9, 2004 – Ms. Ellena Friedman has been appointed Vice President of Communications at the not-for-profit International AIDS Vaccine Initiative (IAVI). Friedman, who officially joined the organization in early Septe
- Senior PR Executive Ellena Friedman Joins IAVI as Vice President of Communications
- Global response to AIDS must include a preventive vaccine
- Statement on DNA.HIVA and MVA.HIVA AIDS vaccine candidates
- IAVI: progress toward an AIDS vaccine outweighed by challenges
- New Options Needed to Prevent the Spread of HIV/AIDS
- IAVI applauds G8 support for an AIDS vaccine
- International development expert Robert Hecht to join IAVI
- Germany begins its first AIDS vaccine trial, partnering with IAVI
- Volunteers sought for AIDS vaccine trial in Amsterdam
- World class AIDS vaccine researcher Emilio Emini joins IAVI
- Targeted Genetics, IAVI, CCRI begin human trial of vaccine candidate to prevent HIV
- Trial of New Investigational AIDS Vaccine Begins in New York and Rochester
- PhRMA report: industry steps up AIDS vaccine and drug research
- IAVI begins AIDS vaccine trials in South Africa, Switzerland
- Thai trial confirms earlier results that VaxGen's AIDSVAX is not efficacious-IAVI response
- IAVI hails start of AIDS vaccine testing in South Africa
- South Africa approves IAVI sponsored AIDS vaccine candidate for human trials
- IAVI hails start of trial in South Africa and US to test AlphaVax's AIDS vaccine
- Statement of IAVI's Seth Berkley on Merck and Aventis partnering to test an AIDS vaccine
- IAVI continues collaboration with Targeted Genetics to develop rAAV AIDS vaccine
- Statement of IAVI's Seth Berkley regarding the results on VaxGen's AIDSVAX
- AIDS Vaccine Trial Begins in Entebbe, Uganda
- Statement of IAVI's Seth Berkley in response to the latest UN HIV/AIDS statistics
- US government starts trial of new AIDS vaccine tailored for multiple subtypes of the virus
- Anticipating the results of the AIDSVAX efficacy trial
- IAVI calls Barcelona AIDS 2002 'a reality check' for vaccines, treatment
- IAVI outlines new R&D agenda to fast-track promising AIDS vaccine candidates
- IAVI Applauds Thailand's Leadership in HIV Vaccine Search
- Kerry-Frist proposed legislation would boost US spending on HIV AIDS prevention and treatment
- Sweden's Bioption, IAVI partnering to develop globally accessible AIDS vaccines
- Global AIDS Fund makes first grants $600 million to prevention and treatment programs
- Pair of IAVI-sponsored AIDS vaccines for Africa shows promise in initial trials, progresses to intermediate testing in UK
- US government announces plans for final stage trial of ALVAC-AIDSVAX in Thailand
- Merck releases promising data from early human studies of two AIDS vaccines
- Advocates seek jump in funding to develop anti-HIV microbicides by 2007
- World Leaders Address Dual Challenges of an AIDS Vaccine
- Berna Biotech teams with IAVI, Gallo lab, Uganda
- Results from Harvard University study underscore need for more AIDS vaccine research
- New partnership to accelerate AIDS vaccine testing, equip developing countries for trials
- IAVI, global partners mark World AIDS Day, continue push to collect Call for Action signatures
- Latest estimates of worldwide AIDS epidemic 65 million infected since 1981
- VaxGen's AIDS vaccine candidate to continue in phase III human testing
- Ugandan Government and IAVI Sign Agreement to Accelerate Testing of AIDS Vaccines
- G8 Leaders Commit US$ 1.3 Billion to Global AIDS Fund
- IAVI Calls for G-8 Leaders to Deliver on Commitments to Speed AIDS Vaccine Development
- IAVI Commends UN Declaration of Commitment to HIV/AIDS Some Crucial Issues Left Unaddressed
- IAVI White Paper Details How Public Sector Can Assure Swift, Global Access to AIDS Vaccines
- IAVI.org Creates Online Campaign to Mobilize Support to Help 'End AIDS for All Time'
- IAVI, Global Partners Mark World AIDS Vaccine Day
- EU, IAVI Strengthen Joint Efforts to Develop and Distribute AIDS Vaccines
- Canadian AIDS Society, IAVI Partner to Advocate for AIDS Vaccines
- Merck Announces Promising Monkey Data for Two AIDS Vaccines
- IAVI and Therion Form Collaboration to Advance Preventive Vaccines for AIDS
- Second IAVI-Sponsored AIDS Vaccine for Africa Enters Human Trials in UK
- Trials of First AIDS Vaccine Candidate Designed for Africa Begin in Nairobi
- IAVI, Maxygen Partner on AIDS Vaccines
- Yahoo! Pledges US$ 5 Million to Support AIDS Vaccine Development
- Bill & Melinda Gates Foundation Pledges US$ 100 Million Toward $550 Million AIDS Vaccine Goal
- Trials of First AIDS Vaccine Candidate Designed for Africa to Begin
- Joint Statement of University of Nairobi, Medical Research Council and IAVI
- IAVI Encouraged by Results of AIDS Vaccine Study in Monkeys
- Presidential Council on AIDS Prioritizes Accelerated Vaccine Development
- IAVI-Sponsored Vaccine is Designed Specifically for Africa
- IAVI Issues Blueprint to Assure Global Access to AIDS Vaccines
- IAVI Welcomes Dutch Government Grant for AIDS Vaccine Development
- IAVI Applauds Launch of NIAID's AIDS Vaccine Development Teams
- New Initiative Includes CAN$ 5 Million Grant to Accelerate Vaccine Development
- Agreements set innovative AIDS vaccine on fast track to developing countries
- IAVI welcomes companies' intent to provide discounted AIDS treatments
- IAVI calls AIDS 2000 boycott threats irresponsible
- IAVI pledges $10 million this year to develop six different AIDS vaccine candidates for world's poorer nations
- IAVI supports UN AIDS ethical guidelines on AIDS vaccine trials
- IAVI, Targeted Genetics Corporation, and Children's Research Institute to Develop AIDS Vaccine
- IAVI applauds Clinton initiative to develop and distribute vaccines in developing countries
- IAVI applauds UN Security Council Session on AIDS in Africa; Calls upon world leaders to finance vaccine development
- The Netherlands announces 5 million guilder grant to IAVI
- New partnership between IAVI and Dutch AIDS Fonds to accelerate development of preventive AIDS vaccine
- IAVI statement on new UNAIDS figures
- IAVI calls for crash programme to develop AIDS vaccine
- African mayors sign call for the development of HIV vaccine
- UK government announces £14 million grant to International AIDS Vaccine Initiative
- Bill and Melinda Gates make US$25 million grant to International AIDS Vaccine Initiative
- IAVI names Wayne Koff Vice President for Research and Development
- Two innovative aids vaccine development partnerships launched
- 12th World conference seen as turning point in AIDS vaccine quest
- New plan to speed AIDS vaccine development released
- International Aids Vaccine Initiative Announces First Research Awards
- 2015
- IAVI in the News
- Partner News
- Events
- HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P)
- AIDS2014: The 20th International AIDS Conference
- 2015 and Beyond: The Role of Innovation for Health in a New Development Framework
- The International Conference on AIDS and STDs in Africa
- First Biennial Scientific Conference on Medicines Regulation in Africa
- UN General Assembly Week 2013
- South African National AIDS Council Biennial Women's HIV Prevention Summit
- AIDS Vaccine 2013
- IAVI and Partners at SA AIDS
- The New York Academy of Sciences - Three Zeros of Eliminating HIV / AIDS: Global Science and Policy
- IAVI CEO Margie McGlynn Testifies Before U.S. House Appropriations Subcommittee on State, Foreign Operations on Funding for AIDS Vaccine R&D
- SUBSCRIPTION CENTER
- Newsletter
